Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types.


Journal

Neurology. Clinical practice
ISSN: 2163-0402
Titre abrégé: Neurol Clin Pract
Pays: United States
ID NLM: 101577149

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 07 11 2023
accepted: 05 02 2024
pmc-release: 01 06 2025
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 9 5 2024
Statut: ppublish

Résumé

Dementia presents not only differing neuropsychiatric symptoms (NPS) across Alzheimer disease (AD), frontotemporal dementia (FTD), dementia with Lewy bodies (DLB) but also subjective cognitive decline (SCD). This study examined sex-based variations in NPS severity and progression across these conditions. We performed a longitudinal cohort study including 1,068 participants. Hierarchical generalized linear mixed models were used to model NPS as a function of disease severity and biological sex at birth. Female participants with AD exhibited NPS more frequently than male participants. In FTD, female participants had more frequent delusions, hallucinations, and depression/dysphoria, while male participants had higher instances of agitation/aggression, apathy, disinhibition, and irritability/lability. In DLB, male participants showed higher instances of depression, and female participants more frequently experienced anxiety. In SCD, female participants showed higher nighttime behaviors. The trajectory of NPS significantly differed between sexes. These findings highlight sex-specific NPS impact in different neurodegenerative conditions.

Sections du résumé

Background and Objectives UNASSIGNED
Dementia presents not only differing neuropsychiatric symptoms (NPS) across Alzheimer disease (AD), frontotemporal dementia (FTD), dementia with Lewy bodies (DLB) but also subjective cognitive decline (SCD). This study examined sex-based variations in NPS severity and progression across these conditions.
Methods UNASSIGNED
We performed a longitudinal cohort study including 1,068 participants. Hierarchical generalized linear mixed models were used to model NPS as a function of disease severity and biological sex at birth.
Results UNASSIGNED
Female participants with AD exhibited NPS more frequently than male participants. In FTD, female participants had more frequent delusions, hallucinations, and depression/dysphoria, while male participants had higher instances of agitation/aggression, apathy, disinhibition, and irritability/lability. In DLB, male participants showed higher instances of depression, and female participants more frequently experienced anxiety. In SCD, female participants showed higher nighttime behaviors. The trajectory of NPS significantly differed between sexes.
Discussion UNASSIGNED
These findings highlight sex-specific NPS impact in different neurodegenerative conditions.

Identifiants

pubmed: 38720954
doi: 10.1212/CPJ.0000000000200299
pii: CPJ-2023-000608
pmc: PMC11073872
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e200299

Informations de copyright

© 2024 American Academy of Neurology.

Auteurs

Chiara Silvestri (C)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Valentina Almici (V)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Ilenia Libri (I)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Irene Mattioli (I)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Maura Cosseddu (M)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Rosanna Turrone (R)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Jasmine Rivolta (J)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Chiara Grassini (C)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Salvatore Caratozzolo (S)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Antonella Alberici (A)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Alessandra Marengoni (A)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Andrea Pilotto (A)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Barbara Borroni (B)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Alessandro Padovani (A)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Alberto Benussi (A)

Department of Clinical and Experimental Sciences (CS, VA, IL, IM, JR, CG, AM, A. Pilotto, BB, A. Padovani, AB), University of Brescia; and Department of Continuity of Care and Frailty (MC, RT, SC, AA), AOU Spedali Civili di Brescia, Italy.

Classifications MeSH